<img height="1" width="1" src="https://www.facebook.com/tr?id=1582471781774081&amp;ev=PageView &amp;noscript=1">
x

A HuGEMM h/mPD1 Mouse Model for Testing Anti-Human PD-1 Therapeutics

The recent approval of two monoclonal antibodies targeting the immune checkpoint programmed cell death-1 (PD-1) protein has fostered the interest around the application of biological therapies targeting PD-1, including new combinatory strategies.